Resource Center

Resource Center

A study in Myanmar published by CHAI and FIND in PLOS shows that integrated HCV and HIV testing on a single platform is feasible, and does not
Read more
CHAI's 2021 Annual Report is out now. In it, we recognize the incredible efforts of our staff during a difficult year.
Read more
CHAI’s recently released Hepatitis C Market Memo is an update to the previous editions of Hepatitis market reports. It provides critical insights into the market and helps the public and private sectors develop better strategies to provide products and services to those who need them. Every 30 seconds, someone loses their life to a hepatitis-related...
Read more
In 2015, CHAI began supporting the Mekong countries—Cambodia, Vietnam, Myanmar, Thailand, and Laos—in reorienting their malaria programs from control to elimination.
Read more
On Nov. 15, 2021 CHAI, MedAccess, and SD Biosensor announced a partnership to increase access to rapid diagnostic tests for syphilis and HIV.
Read more
The report provides market intelligence on hepatitis C diagnostics and drugs in low- and middle-income countries and covers preliminary insights into the hepatitis B market.
Read more
The expanded partnership will increase access to leading-edge cancer treatments in low- and middle-income countries including biologics and hormonal therapies.
Read more
A new article published in BMJ Global Health details results of five years of CHAI support to governments as they initiate and scale up hepatitis C programs across seven low- and middle-income countries.
Read more
At CHAI, our staff is our greatest asset. Our efforts are driven by the talent, creativity, and hard work of our people. This year, for International Women’s Day, we are highlighting several of the women who work at CHAI.
Read more
As we welcome another World Hepatitis Day, the global response to eliminate viral hepatitis as a public threat is accelerating. Viral hepatitis, consisting of hepatitis B (HBV) and hepatitis C (HCV), affects more than 320 million people worldwide, with 90 percent of infections concentrated in low- and middle-income countries. The disease leads to significant liver...
Read more